149 related articles for article (PubMed ID: 22441510)
1. High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis.
Mortensen C; Andersen O; Krag A; Bendtsen F; Møller S
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):619-26. PubMed ID: 22441510
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
[TBL] [Abstract][Full Text] [Related]
3. Cardiac and proinflammatory markers predict prognosis in cirrhosis.
Wiese S; Mortensen C; Gøtze JP; Christensen E; Andersen O; Bendtsen F; Møller S
Liver Int; 2014 Jul; 34(6):e19-30. PubMed ID: 24313898
[TBL] [Abstract][Full Text] [Related]
4. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
Afzelius P; Bazeghi N; Bie P; Bendtsen F; Vestbo J; Møller S
Liver Int; 2011 Oct; 31(9):1381-7. PubMed ID: 21745317
[TBL] [Abstract][Full Text] [Related]
5. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
6. [Influence of anemia on hemodynamic changes in patients with cirrhosis].
Denié C; Poynard T; Gadano A; Vachiery F; Soupison T; Elman A; Valla D; Moreau R; Lebrec D
Gastroenterol Clin Biol; 1997; 21(1):29-33. PubMed ID: 9091387
[TBL] [Abstract][Full Text] [Related]
7. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases.
Yagmur E; Trautwein C; Gressner AM; Tacke F
Am J Gastroenterol; 2006 Jun; 101(6):1244-52. PubMed ID: 16771945
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
Trebicka J; Krag A; Gansweid S; Appenrodt B; Schiedermaier P; Sauerbruch T; Spengler U
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
[TBL] [Abstract][Full Text] [Related]
9. Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosis.
Koch A; Zimmermann HW; Baeck C; Schneider C; Yagmur E; Trautwein C; Tacke F
Clin Biochem; 2012 Apr; 45(6):429-35. PubMed ID: 22285383
[TBL] [Abstract][Full Text] [Related]
10. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
[TBL] [Abstract][Full Text] [Related]
11. Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis.
Zuwała-Jagiełło J; Pazgan-Simon M; Simon K; Warwas M
Acta Biochim Pol; 2011; 58(1):59-65. PubMed ID: 21403920
[TBL] [Abstract][Full Text] [Related]
12. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
13. Implication of inflammation-related cytokines in the natural history of liver cirrhosis.
Girón-González JA; Martínez-Sierra C; Rodriguez-Ramos C; Macías MA; Rendón P; Díaz F; Fernández-Gutiérrez C; Martín-Herrera L
Liver Int; 2004 Oct; 24(5):437-45. PubMed ID: 15482340
[TBL] [Abstract][Full Text] [Related]
14. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.
Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK
J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114
[TBL] [Abstract][Full Text] [Related]
15. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
16. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
Kalabay L; Gráf L; Vörös K; Jakab L; Benko Z; Telegdy L; Fekete B; Prohászka Z; Füst G
BMC Gastroenterol; 2007 Mar; 7():15. PubMed ID: 17394649
[TBL] [Abstract][Full Text] [Related]
17. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin and RANKL in alcoholic liver cirrhosis.
Fábrega E; Orive A; García-Suarez C; García-Unzueta M; Antonio Amado J; Pons-Romero F
Liver Int; 2005 Apr; 25(2):305-10. PubMed ID: 15780054
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
Rincon D; Lo Iacono O; Ripoll C; Gomez-Camarero J; Salcedo M; Catalina MV; Hernando A; Clemente G; Matilla A; Nuñez O; Bañares R
Aliment Pharmacol Ther; 2007 Apr; 25(7):841-8. PubMed ID: 17373923
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
Piechota W; Piechota W
Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
